...BRCA2 mutation status, residual disease after surgery, and disease stage further optimized outcome classification. Ovari...
...BRCA2 (BRCA1/2)-mutated ovarian cancers (BMOC) are exquisitely sensitive to platinum-salts, but resistant to microtubule...
...BRCA2 mutations.,From our population-based case-control study comparing women with CBC to women with unilateral breast c...
...BRCA2-associated pancreatic cancer treated with the poly-(ADP-ribose) polymerase (PARP) inhibitor ABT-888 (veliparib). W...
Germline mutations in BRCA1, BRCA2 and TP53 genes have been identified as one of the most important disease-causing issu...
...BRCA2, Phosphatase and tensin homolog, cellular myelocytomatosis oncogene and NKX3.1 may predict for aggressive high gra...
...BRCA2-deficient cells. Significant potentiation on the cytotoxicity of Temozolomide was also observed. The unique struct...
Germline mutations in the BRCA1 and BRCA2 genes contribute to approximately 18% of hereditary ovarian cancers conferring...
...BRCA2 gene.,We followed 4456 women with a BRCA1 or a BRCA2 mutation for incident cases of endometrial cancer. The incide...
...BRCA2 and 26 non-BRCA1/2) and 15 sporadic tumours in combination with supervised and unsupervised analysis was used to d...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
